Dive into diabetes and GLP-1 with The Diabetes Podcast as Amber Wilhoit (RD/LD, CDCES) and Richie Wilhoit (TRS-C) cut through the hype around Ozempic, Wegovy, and Mounjaro. In this eye-opening episode, we explain how GLP-1 medications work, why they lower A1C, and how they quiet “food noise” by slowing the stomach and supporting insulin when glucose is present. We also get real about side effects like nausea, diarrhea, constipation, “Ozempic face,” and the hidden risk of lean muscle loss. You’ll learn why weight loss often stalls at 6–12 months, why many regain weight after stopping, and what this means for long-term use and cost, including insurance and Medicare realities. We share a real-world story, FDA cautions on compounded semaglutide, and the surprising heart benefits for people with type 2 diabetes. Plus, we preview Part 2: natural ways to boost GLP-1 with food, movement, and simple daily habits. If you’re wondering whether diabetes and GLP-1 meds are right for you, this episode gives you the honest, practical guidance you need.